Thus, elevated levels of α-synuclein increase the activity of the Akt inhibitors phosphatase PP2A [135] and RTP801 [136] while Akt phosphorylation is significantly diminished in dopaminergic SN neurons of PD patients [137]. This evidence concerns the gene AKT1 and Parkinson disease.